Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Serotonin syndrome due to
venlafaxine and maintenance tranylcypromine
therapy.
Hodgman MJ, Martin TG, Krenzelok
EP.
Department of Emergency Medicine, St Joseph Hospital,
Bangor, Maine, USA.
A number of novel serotonergic
antidepressants have been introduced to clinical practice over the last
decade. These medications are felt to be safe alternatives to the
traditional tricyclic antidepressants and monoamine oxidase inhibitors,
particularly in the overdose setting. Serious adverse reactions and drug
interactions have been appreciated and fatalities have been reported. We
describe the development of the serotonin syndrome in a 60 year old
female on chronic tranylcypromine treatment following the inadvertent
ingestion of a single dose of venlafaxine. Manifestations included and
altered mental status that progressed to hyperthermia and coma. She
recovered quickly and without complications. Health care providers and
poison specialists need to be aware that this potentially serious
syndrome can be precipitated by a single dose of a serotonin reuptake
inhibitor in patients being treated with a monoamine oxidase
inhibitor.
Publication Types:
PMID: 9023570 [PubMed - indexed for
MEDLINE]
|